Fine particulate matter (PM(2.5)): The culprit for chronic lung diseases in China.
Fine particulate matter (PM(2.5)): The culprit for chronic lung diseases in China.
复制标题
细颗粒物（PM2.5）：中国慢性肺病的罪魁祸首
DOI：
10.1016/j.cdtm.2018.07.002
复制
发表时间：
2018-09
影响因子：
--
通讯作者：
Zhou LF
中科院分区：
文献类型：
--
作者：
Li T;Hu R;Chen Z;Li Q;Huang S;Zhu Z;Zhou LF
空气污染是一个世界性的公共卫生问题。颗粒物（PM）是空气中固体和液体颗粒的混合物，在我国社会经济发展中日益受到关注。几十年来，流行病学研究已经证实了细颗粒物污染物与呼吸道疾病之间的联系。据报道，不同人群中细颗粒物（PM2.5）浓度的增加会导致对呼吸道疾病（包括急性呼吸窘迫、哮喘、慢性阻塞性肺病和肺癌）的易感性增加。本文就PM2.5在呼吸系统疾病中的病理生理机制进行综述，以期对大气污染的防治和呼吸道炎症性疾病的治疗有所帮助。
Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased Fine particulate matter (PM2.5) concentrations cause elevated susceptibility to respiratory diseases, including acute respiratory distress, asthma, chronic obstructive pulmonary disease, and lung cancer. This review will discuss the pathophysiology of PM2.5 in respiratory diseases, which are helpful for the prevention of air pollution and treatment of respiratory tract inflammatory diseases.